GSK has escalated a dispute over rights to its cancer immunotherapy Jemperli, after its subsidiary Tesaro filed a complaint ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

Leela Barham highlights data that shows that indication-specific pricing has been used in England for at least four years and ...

Now in its 7th year, our free-to-attend careers event will be held at the Royal Society of Medicine on the 18th February 2026 ...

Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel ...

Indeed, creating a ‘smart investment strategy’ offers wide-ranging benefits – healthcare providers can innovate, patients ...

Personalised cell therapy developer Aspen Neuroscience added $115 million to its cash reserves with a Series C that included ...

The ruling by reimbursement authority NICE means that Amvuttra (vutrisiran) can be used to treat wild-type or hereditary ATTR ...

At ESMO 2025, pharmaphorum spoke with Dr Ebrahim Delpassand, CEO of RadioMedix, an emerging, clinical-stage biotech company ...

Medscape has joined the ranks of companies offering a generative AI chatbot to support clinical decision-making and help ease ...

A mental health campaigner has condemned the "stunning silence" from mainstream media in the UK after the first-ever men's ...

As part of the 2024 VPAG, there was an agreement to conduct operational review meetings every six months. The first ...